Princeton Global Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Princeton Global Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.03M	Sell	6,041 -442	-7%	-$212K	0.43%	61
2026 Q1	$3.19M	Sell	6,483 -6	-0.1%	-$3.26K	0.52%	56
2025 Q4	$3.76M	Sell	6,489 -762	-11%	-$431K	0.61%	44
2025 Q3	$3.52M	Sell	7,251 -99	-1%	-$46.1K	0.58%	49
2025 Q2	$2.98M	Sell	7,350 -188	-2%	-$78.6K	0.54%	55
2025 Q1	$3.75M	Sell	7,538 -258	-3%	-$140K	0.74%	37
2024 Q4	$4.06M	Sell	7,796 -371	-5%	-$204K	0.76%	36
2024 Q3	$5.05M	Buy	8,167 +191	+2%	+$113K	0.98%	26
2024 Q2	$4.41M	Buy	7,976 +301	+4%	+$172K	0.97%	26
2024 Q1	$4.46M	Sell	7,675 -650	-8%	-$365K	1.06%	26
2023 Q4	$4.42M	Buy	8,325 +3	+0%	+$1.45K	1.11%	23
2023 Q3	$4.21M	Buy	8,322 +1,204	+17%	+$642K	1.2%	22
2023 Q2	$3.71M	Sell	7,118 -2,494	-26%	-$1.35M	1.09%	25
2023 Q1	$5.54M	Buy	9,612 +115	+1%	+$64.8K	1.59%	13
2022 Q4	$5.23M	Sell	9,497 -35	-0.4%	-$18.5K	1.69%	11
2022 Q3	$4.83M	Buy	9,532 +25	+0.3%	+$14K	1.69%	12
2022 Q2	$5.17M	Sell	9,507 -64	-0.7%	-$35.2K	1.67%	11
2022 Q1	$5.65M	Sell	9,571 -63	-0.7%	-$36.2K	1.57%	13
2021 Q4	$6.43M	Sell	9,634 -284	-3%	-$177K	1.8%	11
2021 Q3	$5.67M	Buy	9,918 +435	+5%	+$239K	1.73%	10
2021 Q2	$4.78M	Sell	9,483 -219	-2%	-$103K	1.46%	16
2021 Q1	$4.43M	Buy	9,702 +4	+0%	+$1.91K	1.43%	17
2020 Q4	$4.52M	Sell	9,698 -55	-0.6%	-$25.8K	1.58%	14
2020 Q3	$4.31M	Sell	9,753 -2,346	-19%	-$969K	1.74%	11
2020 Q2	$4.38M	Buy	12,099 +121	+1%	+$40.6K	1.37%	15
2020 Q1	$3.4M	Buy	11,978 +1,329	+12%	+$419K	1.5%	15
2019 Q4	$3.46K	Buy	10,649 +802	+8%	+$243K	1.4%	16
2019 Q3	$2.83M	Buy	9,847 +273	+3%	+$78.2K	1.61%	13
2019 Q2	$2.81M	Buy	9,574 +117	+1%	+$32.2K	1.69%	12
2019 Q1	$2.59M	Buy	9,457 +4,477	+90%	+$1.11M	1.77%	13
2018 Q4	$1.11M	Buy	+4,980	New	+$1.17M	0.98%	32

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Princeton Global Asset Management's TMO Position: Q2 2026 in Review

Princeton Global Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 6.8% in Q2 2026, selling an estimated $212K and leaving 6,041 shares worth $3.03M. The position accounts for 0.43% of the portfolio, ranked #61.

Princeton Global Asset Management first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.43M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Princeton Global Asset Management held 6,041 shares of Thermo Fisher Scientific worth $3.03M as of Q2 2026.
Princeton Global Asset Management sold 442 Thermo Fisher Scientific shares in Q2 2026, an estimated $212K.
Thermo Fisher Scientific made up 0.43% of Princeton Global Asset Management's portfolio in Q2 2026, its #61 holding.
Princeton Global Asset Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
Princeton Global Asset Management's Thermo Fisher Scientific position peaked at $6.43M in Q4 2021.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.